Name PRICE MARKET CAPITALIZATION PRICE TO EARNINGS RATIO DIVIDEND YIELD SYMBOL EXCHANGE PRICE PERCENT DIFFERENCE YEAR TO DATE PRICE PERCENT DIFFERENCE 5 YEAR CHART 1 YEAR CHART

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

https://www.fibrogen.com


FGEN $52.98 -2.64 (-4.75%)
Sector Health Care
Industry Biotech & Pharma
Market Cap 4.53 Billion
EPS 0.25 P/E Ratio 0.00
Previous Earnings Tue, Aug 7, 2018
Latest Earnings Thu, Nov 8, 2018
Dividend --
Ex-Date --
Dividend Pay Date --
Dividend History --

52.98 4.53 0.00 0.00 FGEN NASDAQ -4.75 15.63 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=FGEN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=FGEN&exchange=NASDAQ&chart=1

Symbol Surfing has been referenced on Barrons, CNN & Investor Place.

About | Blog | Advertising | Terms | info@symbolsurfing.com

Investing Quotes #Legendary


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Some links on this website are advertisements and/or affiliate links and Symbol Surfing receives compensation.

©2019 Symbol Surfing All Rights Reserved. Privacy Policy | ^Top